This proposal is shared with intended recipients only. Please enter the access code provided.
A curated library of fifteen AI agents, each one a digital team member built for a specific pharma workflow across regulatory, export, QA, manufacturing, sales, and finance.
Manufacturing capacity is no longer the constraint. The bottleneck has shifted to documentation, regulatory follow-through, and the cross-team coordination that holds it all together.
Document review, dossier preparation, exception detection, follow-up coordination, status tracking. The work is repetitive enough to automate but consequential enough to need a human approver. That is the sweet spot.
Agents prepare, draft, surface, and flag. Humans approve, release, and sign. Compliance authority stays with the qualified people Medopharm employs today. The audit trail shows who decided what, and when.
Each agent is a self-contained digital operator with a defined input, defined output, and a clear handoff to a human reviewer.
Four priority workflows mapped node by node. Every agent has a trigger, reads from specific systems, prepares a draft or decision packet, hands off to a human approver, and produces a measurable outcome. No black boxes.
Ranked by volume of repetitive work, downstream cost of delay, and ease of integration with existing systems.
Headline ROI is cost recovery. Same teams, more output. Less manual effort, fewer delays, no headcount growth in lockstep with business volume.
No big-bang deployment. Start narrow, prove the model on one high-ROI agent, expand only after Medopharm's teams are convinced.
We sit with RA, QA, exports, and planning teams. Map real handoffs, not the org chart. Find the actual paper trail before designing the agent.
Connect ERP, document repositories, email, and shared drives. Establish read/write boundaries, permissions, and audit logging before any agent runs.
Build the first agent against Medopharm's real document types and vocabulary. Tested against historical data before going live. Reviewed by domain experts.
Deploy with review queues, exception handling, and accountability owners. KPI baseline captured before launch so impact is measurable from day one.
The "how do we control this?" question gets answered up front, not in a footnote. These controls travel with every agent we deploy.
An AI agent that runs without controls is not a tool. It is a risk. These four controls are non-negotiable on every agent we deploy.
Agents only read and write the systems, folders, and document types their workflow permits. Role-based, scoped to the task.
RA, QA, PV, and commercial decisions require sign-off from qualified Medopharm personnel before any release. Agents prepare, humans approve.
Every draft, edit, source document, system read, and approval is logged with timestamp and identity. Inspection-ready by default.
Agents retrieve from approved SOPs, templates, and controlled document stores. No invented content, no hallucinated dosages, no off-script answers.
A 90-day pilot on the highest-impact workflow. Measurable outcome. Then we scale based on what the data shows, not what the deck claims.